scispace - formally typeset
D

David Bloxham

Researcher at Cambridge University Hospitals NHS Foundation Trust

Publications -  26
Citations -  2098

David Bloxham is an academic researcher from Cambridge University Hospitals NHS Foundation Trust. The author has contributed to research in topics: Myeloid & Karyotype. The author has an hindex of 12, co-authored 25 publications receiving 1881 citations. Previous affiliations of David Bloxham include University of Cambridge.

Papers
More filters
Journal ArticleDOI

Deletion of chromosome 20q in myelodysplasia can occur in a multipotent precursor of both myeloid cells and B cells.

TL;DR: This represents the first report in which a chromosome abnormality associated with MDS has been immortalized in an EBV-transformed lymphoblastoid cell line and shows that patients with apparent myeloid restriction of a chromosome deletion may in fact have a disease arising in a multipotent cell with both myeloids and lymphoid potential.
Journal ArticleDOI

Philadelphia-negative chronic myeloid leukaemia: detection by FISH of BCR-ABL fusion gene localized either to chromosome 9 or chromosome 22.

TL;DR: In one patient, analysis of metaphase spreads showed that the 3’region of the ABL gene was deleted from one chromosome 9 and inserted into chromosome 22, and in a second patient 5’BCR sequences were missing from one copy of chromosome22, and co‐localized with 3'ABL sequences on chromosome 9.
Journal ArticleDOI

Molecular detection of clonally rearranged cells in peripheral blood progenitor cell harvests from multiple myeloma patients.

TL;DR: Peripheral blood progenitor cells (PBPC) are increasingly used for autologous reconstitution following high‐dose chemotherapy in multiple myeloma but it is unclear whether these cells are less likely to be contaminated with malignant cells than bone marrow.